US 11,725,183 B2
Method of culturing segmented filamentous bacteria in vitro
Gerard Eberl, Paris (FR); David Bikard, Paris (FR); Pamela Schnupf, Paris (FR); Nadine Cerf Bensussan, Paris (FR); Valerie Gaboriau-Routhiau, Clamart (FR); and Philippe Sansonetti, Paris (FR)
Assigned to INSTITUT PASTEUR, Paris (FR); FONDATION IMAGINE, Paris (FR); ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, Paris (FR); UNIVERSITE PARIS CITE, Paris (FR); and INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), Paris (FR)
Filed by INSTITUT PASTEUR, Paris (FR); FONDATION IMAGINE, Paris (FR); ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, Paris (FR); UNIVERSITE PARIS DESCARTES, Paris (FR); and INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (IN-SERM), Paris (FR)
Filed on Aug. 22, 2019, as Appl. No. 16/548,280.
Application 16/548,280 is a continuation of application No. 15/538,184, granted, now 10,435,665, previously published as PCT/IB2015/059948, filed on Dec. 23, 2015.
Claims priority of application No. PCT/IB2014/067285 (WO), filed on Dec. 23, 2014.
Prior Publication US 2019/0367867 A1, Dec. 5, 2019
This patent is subject to a terminal disclaimer.
Int. Cl. C12N 1/20 (2006.01); C12N 15/74 (2006.01); C12N 13/00 (2006.01)
CPC C12N 1/20 (2013.01) [C12N 13/00 (2013.01); C12N 15/74 (2013.01); C12N 2502/23 (2013.01)] 12 Claims
 
1. A genetically modified segmented filamentous bacteria (SFB) strain expressing a foreign antigen of interest obtained from a microorganism or a cell different from a SFB.